← All trials
NCT06212388
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 24, 2024
- Primary completion
- Oct 30, 2027
- Completion date
- Oct 30, 2028
- First posted
- Jan 18, 2024
- Last posted
- Jan 25, 2024
- Enrollment
- 10
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Xijing HospitalLead sponsor
- Beijing GD Initiative Cell Therapy Technology Co.，Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.